BioPower Operations Corporation
BOPO
$0.0001
$0.000.00%
| 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 125.00K | 371.70K | 571.70K | 746.70K | 621.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 125.00K | 371.70K | 571.70K | 746.70K | 621.70K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 125.00K | 371.70K | 571.70K | 746.70K | 621.70K |
| SG&A Expenses | 5.30M | 1.06M | 1.16M | 1.02M | 817.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.98M | 1.50M | 1.16M | 1.02M | 817.00K |
| Operating Income | -5.85M | -1.12M | -591.80K | -272.40K | -195.30K |
| Income Before Tax | -6.17M | -1.42M | -792.50K | -379.80K | -380.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.17 | -1.42 | -0.79 | -0.38 | -0.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.17M | -1.42M | -792.50K | -379.80K | -380.30K |
| EBIT | -5.85M | -1.12M | -591.80K | -272.40K | -195.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.13 | -0.03 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.08 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.13 | -0.03 | -0.02 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.08 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 182.39M | 182.12M | 181.50M | 182.00M | 180.04M |
| Average Diluted Shares Outstanding | 182.39M | 182.12M | 181.50M | 182.00M | 180.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
